Communication for the Heartland Regional Genetics Group


Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
"Williamson, Lori L. (HSC)" <[log in to unmask]>
Reply To:
Communication for the Heartland Regional Genetics Group <[log in to unmask]>
Wed, 5 Apr 2006 13:54:02 -0500
text/plain (86 lines)
Heartlanders......some of you may have rec'd this, but for those who did

Lori Williamson, MS, CGC

Subject: [NBS-LIST] US Army Call for Medical Research Proposals

For your information and consideration:

Fiscal Year 2006 Peer Reviewed Medical Research Program (PRMRP) Call For

The United States Army Medical Research and Materiel Command (USAMRMC),
Office of the Congressionally Directed Medical Research Programs (CDMRP)
invites applications for funding for the PRMRP. Five different funding
mechanisms that provide support for military health-related research are
available. Those mechanisms include: Investigator-Initiated Award, New
Program Project Award, Existing Program Project Award,  Advanced
Technology: Product/Technology Down-Selection or Optimization Award, and
Advanced Technology: Clinical Testing/Trials (Human Subjects) Award.

Proposals must address one of the following topic areas: Advanced
Proteomics, Alcoholism Research, Autism, Autoimmune Diseases (such as
Scleroderma and Sjogren's Syndrome), Blood-Related Cancer Research (such
as Leukemia, Lymphoma, and Multiple Myeloma), Childhood Asthma, Chronic
Pain and Fatigue Research, Childhood Cancer Research, Diabetes Research,
Duchenne's Disease Research, Eye and Vision Research, Fibromyalgia,
Interstitial Cystitis Syndrome, Kidney Cancer Research, Lupus Research,
Osteoporosis and Bone-Related Diseases, Polycystic Kidney Disease,
Pulmonary Hypertension, Paget's Disease, Post traumatic Stress
Disorders, Social Work Research, and Military Relevant Disease
Management [with special emphasis on Antibiotic Resistance;
Neurotoxicity of Mefloquine;  Rehabilitation (Face and/or Eye Injury);
Respiratory Infection Including Associated Respiratory Disease; Drug
Abuse; Efficacy and Subsequent Clinical Guidelines for the Use of
Probenecid or Other Drugs to Decrease Dosage Requirements of Oseltamivi
r Phosphate for the Treatment of Influenza; Human Performance
Optimization; Radio-Protectants; and  Mental Health Resiliency].

The PRMRP expects to fund 33 Investigator -Initiated Research Awards at
$625,000 direct costs,   2 New Program Project Awards at $1.25M direct
costs , 2 Existing program Project Awards at $1,25M, 3 Advanced
Technology: Product/Technology Down Selection or Optimization at
$940,000 direct costs, 2 Advanced technology: Clinical testing/Trials at
$2.5M direct costs.  All mechanism can request applicable indirect costs
in addition to direct cost amounts.

Please see FY06 PRMRP Supplement for complete details for submission
under this announcement.  Please note that this supplement is
self-contained; all information and forms needed for successful proposal
submission are included within this document.
Electronic submission is required.  Proposals will be accepted only as
PDF files submitted through the CDMRP eReceipt system at
https://cdmrp.org. A link to the document can also be found at the CDMRP
website (http://cdmrp.army.mil).

No paper copy submissions will be accepted.  The CDMRP uses a two -tier
review process for proposals:  Scientific peer review, followed by
programmatic review.  Details of both tiers of review can be found in
the Full Text of the Announcement at .  Timelines for the FY06 PRMRP
proposals are as follows:  Letter of Intent are expected by April 10,
2006, Full Proposal Submission Deadline: May 9, 2006, 5:00 p.m. Easter
Time; Peer Review: July 2006, Programmatic review: September 2006; Award
start date:  Between October 2006 and September 2007.  For additional
information or questions, please contact Brian E. Martin,
Contracting/Grants Officer, U.S. Army Medical research Acquisition
Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, phone (301)
619-8808, Fax (301) 619-4084, e-mail : [log in to unmask]

Brad Therrell, Ph.D., Professor
Dept. of Pediatrics, UTHSCSA
Director, National Newborn Screening and
     Genetics Resource Center (NNSGRC)
1912 W. Anderson Lane #210
Austin, Texas 78757
Phone 512-454-6419  Fax 512-454-6509
Visit our website:  http://genes-r-us.uthscsa.edu